These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 788065)

  • 1. [Treatment of hyperlipidemia with a new drug, tibric acid].
    Carmena R; González R Florez J; Sanchis J
    Rev Clin Esp; 1976 Jul; 142(2):151-5. PubMed ID: 788065
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of tibric acid, a new hypolipidemic agent].
    Noseda G; Sirtori CR
    Schweiz Med Wochenschr; 1974 Dec; 104(51):1917-22. PubMed ID: 4438990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of the dose-response curve of a new hypolipidemic molecule: tibric acid (CP-18524). Methodologic and statistical aspects].
    Bielmann P; Annable L; Brun D; Moorjani S; Lupien PJ; Tétreault L
    Union Med Can; 1975 Jun; 104(6):930-4. PubMed ID: 1224412
    [No Abstract]   [Full Text] [Related]  

  • 4. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
    G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of tibric acid (CP-18.254) on plasma lipids in patients with primary endogenous hyperlipoproteinemia].
    Lisch HJ; Sailer S; Braunsteiner H
    Arzneimittelforschung; 1977; 27(10):2017-20. PubMed ID: 579116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 7. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experimentation with a new drug lowering blood lipids (Tiadenol)].
    Potì R; Quintavalla R; Manotti C
    G Clin Med; 1977; 58(7-8):293-300. PubMed ID: 336442
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].
    Passeri M; Cocchi C; Ceccato S; Palummeri E; Cucinotta D
    G Clin Med; 1979 Jan; 60(1):49-64. PubMed ID: 456778
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
    Lageder H; Irsigler K
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):71-5. PubMed ID: 798199
    [No Abstract]   [Full Text] [Related]  

  • 11. [The management of hyperlipoproteinemia with Liproreduct].
    Fenster R
    Ther Ggw; 1974 May; 113(5):813-24. PubMed ID: 4603893
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effects of bezafibrate in hyperlipidemia].
    Kunesová M; Honková M; Zeman M; Mares P; Skorepa J
    Cas Lek Cesk; 1983 May; 122(20):628-31. PubMed ID: 6342789
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H; Jaillard J
    Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract]   [Full Text] [Related]  

  • 14. [First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
    Wolfram G; Keller C; Kilani C; Zöllner N
    Verh Dtsch Ges Inn Med; 1973; 79():1291-3. PubMed ID: 4597609
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acipimox treatment of hyperlipidemia type II].
    Noseda G; Fragiacomo C; Cairoli R
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1790-1. PubMed ID: 6758114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of tiadenol in prolonged therapy of hyperlipoproteinemias (type IIa-IIb)].
    Rouffy J
    Therapie; 1975; 30(6):815-23. PubMed ID: 785682
    [No Abstract]   [Full Text] [Related]  

  • 19. Choosing drug therapy for patients with hyperlipidemia.
    Safeer RS; Lacivita CL
    Am Fam Physician; 2000 Jun; 61(11):3371-82. PubMed ID: 10865931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].
    Warembourg H; Ketelers JY; Ginestet A
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1331-5. PubMed ID: 4608970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.